1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7- (3-methyl-1-piperazinyl) -4-oxo-3-quinolinecarboxylic Acid CAS 112811-59-3

Khoom Piav Qhia:

Khoom Lub Npe:

1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7- (3-methyl-1-piperazinyl) -4-oxo-3-quinolinecarboxylic acid CAS TSIS TAU: 112811-59-3

Lub ntsiab lus:

Gatifloxacin;

Gatifloxacin API;

PD 135432;

Tshuaj& Lub Cev Muaj Zog:

Tsos: Dawb hmoov

Kev Ntsuas: ≥99.00%

Ceev: 1.386 g/cm3

Kub Point: 607.8 ℃ ntawm 760 mmHg

Melting Point: 162 ℃ Cov

Flash Point: 321.4 ℃

Refractive Index: 1.616

Kev Cia Cia: Khaws ntawm 0-5 ℃

Vapor Siab: 1.26E-15mmHg ntawm 25 ℃

Cov Ntaub Ntawv Kev Nyab Xeeb:

RTECS: BT1750000

Cov Lus Hais Txog Kev Nyab Xeeb: S26; S36/37/39; S37/39

HS Code: 2933990090

Cov nqe lus pheej hmoo: R20/21/22; R36/37/38

Cov lej phom sij: Xn

Gatifloxacin yog tshuaj tua kab mob ntawm tsev neeg fluoroquinolone plaub tiam, nws txwv cov kab mob enzyme DNA gyrase thiab topoisomerase IV. gyrase thiab topoisomerase IV. Gatifloxacin muaj kev ua haujlwm sib npaug ntawm tosufloxacin thiab kev ua haujlwm muaj zog ntau dua li ntawm norfloxacin, ofloxacin, ciprofloxacin, thiab sparfloxacin tiv thaiv kev hloov pauv thib ob (grlA gyrA; gatifloxacin MIC ntau, 1.56 txog 3.13 microg/ml) thiab muaj cov haujlwm feem ntau tiv thaiv peb cov kauj ruam thib peb (grlA gyrA grlA; gatifloxacin MIC ntau, 1.56 txog 6.25 microg/ml), qhia tias gatifloxacin muaj lub zog ua haujlwm tshaj plaws tiv thaiv ib leeg hloov pauv topo IV thiab hu ua mutated DNA gyrase ntawm quinolones kuaj.Ophthalmic gatifloxacin 0.3 % tsawg kawg li ua tau zoo li ciprofloxacin ntawm kev kho qhov txhab ntawm lub qhov muag uas kis nrog Pseudomonas aeruginosa thaum siv gatifloxacin tsawg dua li ciprofloxacin. Cov kev nyiam nyiam gatifloxacin hauv cov qhab nia khaws cia hauv fluorescein .Qhov kev qhia paub: Kab mob kis tau los ntawm FDA Pom Zoo Hnub: Toxicity: Hepatotoxicity; Mob pancreatitis mob hnyav; Torsades tsib pointes

Yog tias koj txaus siab rau peb cov khoom lossis muaj lus nug, thov koj xav tiv tauj peb!

Cov khoom lag luam nyob rau hauv patent tau muab rau R& D lub hom phiaj nkaus xwb. Txawm li cas los xij, lub luag haujlwm zaum kawg tshwj xeeb tshaj yog nrog tus neeg yuav khoom.

Cim npe nrov: 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7- (3-methyl-1-piperazinyl) -4-oxo-3-quinolinecarboxylic acid cas 112811-59-3, tuam ntxhab, cov chaw muag khoom, lub Hoobkas , yuav, hauv Tshuag

• Tug: Gatifloxacin Hydrochloride CAS 160738-57-8
• Tom ntej: (2S, 3aS, 7aS) -Benzyl Octahydro-1H-indole-2-carboxylate 4-methylbenzenesulfonate CAS 94062-52-9